| 1 | [SID57287618] | Active | IC50 | 1.49 | Confirmation of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. [AID1535, Type: confirmatory] | MPI protein [Homo sapiens] [gi:16878311] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 57287618 | | CID | 22416276 | | Outcome | Active | | IC50 | 1.49 [uM] | | BioAssay | Confirmation of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. | | AID | 1535 | | BioAssay type | confirmatory | | Target | MPI protein [Homo sapiens] [gi:16878311] | | PubMed | | | Data Table |  |
|
| 2 | [SID57287618] | Active | IC50 | 1.49 | Confirmation of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. [AID1535, Type: confirmatory] | MPI protein [Homo sapiens] [gi:16878311] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 57287618 | | CID | 22416276 | | Outcome | Active | | IC50 | 1.49 [uM] | | BioAssay | Confirmation of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. | | AID | 1535 | | BioAssay type | confirmatory | | Target | MPI protein [Homo sapiens] [gi:16878311] | | PubMed | | | Data Table |  |
|
| 3 | [SID85147393] | Active | Potency | 1.9953 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 4 | [SID85147393] | Active | Potency | 1.9953 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 5 | [SID85147393] | Active | Potency | 3.2643 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 3.2643 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID85147393] | Active | Potency | 3.2643 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 3.2643 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID85147393] | Active | Potency | 3.2643 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 3.2643 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID85147393] | Active | Potency | 3.3808 | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase [AID485367, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 3.3808 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase | | AID | 485367 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 9 | [SID85147393] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 10 | [SID85147393] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 11 | [SID85147393] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 12 | [SID85147393] | Active | Potency | 4.4668 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 4.4668 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 13 | [SID85147393] | Active | IC50 | 5.102 | Fluorescence-based cell-based high throughput dose response assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID651553, Type: confirmatory] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | IC50 | 5.102 [uM] | | BioAssay | Fluorescence-based cell-based high throughput dose response assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 651553 | | BioAssay type | confirmatory | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 14 | [SID85147393] | Active | IC50 | 5.102 | Fluorescence-based cell-based high throughput dose response assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID651553, Type: confirmatory] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | IC50 | 5.102 [uM] | | BioAssay | Fluorescence-based cell-based high throughput dose response assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 651553 | | BioAssay type | confirmatory | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 15 | [SID85147393] | Active | Potency | 5.6234 | qHTS Assay for Inhibitors of the HIV-1 protein Vpr [AID651644, Type: confirmatory] | Vpr [Human immunodeficiency virus 1] [gi:28872817] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS Assay for Inhibitors of the HIV-1 protein Vpr | | AID | 651644 | | BioAssay type | confirmatory | | Target | Vpr [Human immunodeficiency virus 1] [gi:28872817] | | PubMed | | | Data Table |  |
|
| 16 | [SID85147393] | Active | Potency | 8.9125 | qHTS of Trypanosoma Brucei Inhibitors [AID624173, Type: confirmatory] | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS of Trypanosoma Brucei Inhibitors | | AID | 624173 | | BioAssay type | confirmatory | | Target | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] | | PubMed | | | Data Table |  |
|
| 17 | [SID85147393] | Active | Potency | 10 | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 18 | [SID85147393] | Active | Potency | 10 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 19 | [SID85147393] | Active | Potency | 10 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 20 | [SID85147393] | Active | Potency | 10.4179 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 10.4179 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID85147393] | Active | IC50 | 12.4 | Dose Response confirmation of small molecule APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID504719, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | IC50 | 12.4 [uM] | | BioAssay | Dose Response confirmation of small molecule APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 504719 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 22 | [SID85147393] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 23 | [SID85147393] | Active | Potency | 15.8489 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 24 | [SID85147393] | Active | Potency | 15.8489 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 25 | [SID85147393] | Active | Potency | 15.8489 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 26 | [SID85147393] | Active | Potency | 15.8489 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 27 | [SID57287618] | Active | IC50 | 18.1 | Counter screen SAR assay for PMM2 inhibitors via a fluorescence intensity assay [AID1655, Type: confirmatory] | phosphomannomutase 2 [Homo sapiens] [gi:4557839] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 57287618 | | CID | 22416276 | | Outcome | Active | | IC50 | 18.1 [uM] | | BioAssay | Counter screen SAR assay for PMM2 inhibitors via a fluorescence intensity assay | | AID | 1655 | | BioAssay type | confirmatory | | Target | phosphomannomutase 2 [Homo sapiens] [gi:4557839] | | PubMed | | | Data Table |  |
|
| 28 | [SID57287618] | Active | IC50 | 18.1 | Counter screen SAR assay for PMM2 inhibitors via a fluorescence intensity assay [AID1655, Type: confirmatory] | phosphomannomutase 2 [Homo sapiens] [gi:4557839] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 57287618 | | CID | 22416276 | | Outcome | Active | | IC50 | 18.1 [uM] | | BioAssay | Counter screen SAR assay for PMM2 inhibitors via a fluorescence intensity assay | | AID | 1655 | | BioAssay type | confirmatory | | Target | phosphomannomutase 2 [Homo sapiens] [gi:4557839] | | PubMed | | | Data Table |  |
|
| 29 | [SID85147393] | Active | IC50 | 39.27 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens [AID624330, Type: confirmatory] | RACGAP1 gene product [Homo sapiens] [gi:21361397] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | IC50 | 39.27 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens | | AID | 624330 | | BioAssay type | confirmatory | | Target | RACGAP1 gene product [Homo sapiens] [gi:21361397] | | PubMed | | | Data Table |  |
|
| 30 | [SID85147393] | Active | CC50 | 77.268 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - HeLa Cytotoxicity [AID624300, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | CC50 | 77.268 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - HeLa Cytotoxicity | | AID | 624300 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID85147393] | Active | Potency | 79.4328 | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). [AID588795, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). | | AID | 588795 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 32 | [SID85147393] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 33 | [SID85147393] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 34 | [SID85147393] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 35 | [SID85147393] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 36 | [SID85147393] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 37 | [SID85147393] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 38 | [SID85147393] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 39 | [SID85147393] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 40 | [SID85147393] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 41 | [SID85147393] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 42 | [SID85147393] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 43 | [SID85147393] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 44 | [SID85147393] | Active | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) [AID434962, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) | | AID | 434962 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 45 | [SID85147393] | Active | | | Fluorescence polarization-based cell-based high throughput confirmation assay for inhibitors of insulin-degrading enzyme (IDE) [AID435028, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | Fluorescence polarization-based cell-based high throughput confirmation assay for inhibitors of insulin-degrading enzyme (IDE) | | AID | 435028 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 46 | [SID85147393] | Active | | | Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective agonists [AID651787, Type: screening] | GNA15 gene product [Homo sapiens] [gi:156104883] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective agonists | | AID | 651787 | | BioAssay type | screening | | Target | GNA15 gene product [Homo sapiens] [gi:156104883] | | PubMed | | | Data Table |  |
|
| 47 | [SID85147393] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 48 | [SID85147393] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 85147393 | | CID | 22416276 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 49 | [SID57287618] | Active | | | Toxicity Screening of PMI Inhibitors in Hela cells [AID1620, Type: other] | MPI protein [Homo sapiens] [gi:16878311] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 57287618 | | CID | 22416276 | | Outcome | Active | | BioAssay | Toxicity Screening of PMI Inhibitors in Hela cells | | AID | 1620 | | BioAssay type | other | | Target | MPI protein [Homo sapiens] [gi:16878311] | | PubMed | | | Data Table |  |
|
| 50 | [SID57287618] | Active | | | Toxicity Screening of PMI Inhibitors in Hela cells [AID1620, Type: other] | MPI protein [Homo sapiens] [gi:16878311] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 57287618 | | CID | 22416276 | | Outcome | Active | | BioAssay | Toxicity Screening of PMI Inhibitors in Hela cells | | AID | 1620 | | BioAssay type | other | | Target | MPI protein [Homo sapiens] [gi:16878311] | | PubMed | | | Data Table |  |
|